Effects of the Oral Care With Vaccines for Pneumonia in Elderly; Going Home Together Both Physician and Dentist

Yubari Kibounomori

Status: Completed

Conditions: Pneumonia

Treatments: Other: Specific frequency of oral care; Biological: Pneumococcal vaccination (Pneumovax NP, 21800AMY10131000); Biological: Influenza vaccination (Flubik HA, 16100EZZ01207000)

Study type: Interventional

Funder types: Other

Identifiers

NCT01403805

803121

Details and patient eligibility

About

Prospective study comparing the effects of interventions (combined oral care and pneumococcal plus influenza vaccinations) in preventing pneumonia and increasing the survival rate from pneumonia.

Full description

The elderly population can be expected to increase not only in developed countries, but also in developing countries. Pneumonia is one of the most common causes of death in the elderly.

The investigators conducted a prospective study comparing the effects of interventions (combined oral care and pneumococcal plus influenza vaccinations) in preventing pneumonia and increasing the survival rate from pneumonia in consecutive elderly patients at a nursing home in Yubari during one year from 2009, with the results in a non-intervention group.

Enrollment: 199 patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• The residents or an agent who understand the purpose of this study and give informed consent.

Exclusion criteria

• The residents contraindicated to vaccine

Trial design

Primary purpose: Prevention

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

199 participants in 2 patient groups

Oral care and vaccines

Experimental group

Description:

Oral care and pneumococcal plus influenza vaccines

Treatment:

Biological: Pneumococcal vaccination (Pneumovax NP, 21800AMY10131000)

Other: Specific frequency of oral care

Biological: Influenza vaccination (Flubik HA, 16100EZZ01207000)

Biological: Influenza vaccination (Flubik HA, 16100EZZ01207000)

Vaccine

Active Comparator group

Description:

Influenza vaccine only

Treatment:

Biological: Influenza vaccination (Flubik HA, 16100EZZ01207000)

Biological: Influenza vaccination (Flubik HA, 16100EZZ01207000)